FRESH-PEF167-en
Study of the PREValence of persistent Severe poorly controlled Asthma
PREVAS
| Name | Country code |
|---|---|
| France | fr |
['Clinical data']
Individuals
| Topic | Vocabulary |
|---|---|
| Pulmonary medicine | health theme |
| Asthma | cim-11 |
{"level_sex_clusion_I":[{"value":"Male","concept":{"vocab":"MeSH","vocabURI":"D008297"}},{"value":"Female","concept":{"vocab":"MeSH","vocabURI":"D005260"}}],"level_age_clusion_I":[{"value":"Young Adult (19 to 24 years)","concept":{"vocab":"MeSH","vocabURI":"D055815"}},{"value":"Adult (25 to 44 years)","concept":{"vocab":"MeSH","vocabURI":"D000328"}},{"value":"Middle Aged (45 to 64 years)","concept":{"vocab":"MeSH","vocabURI":"D008875"}},{"value":"Aged (65 to 79 years)","concept":{"vocab":"MeSH","vocabURI":"D000368"}}],"level_type_clusion_I":"Patients population","level_type_clusion_other":"","clusion_I":"severe persistent asthmatic patients viewed in routine consultation, with controledl or uncontrolled asthma in the previous year.","clusion_E":""}
| Name |
|---|
| Anne;PONTHIEUX |
| Name | Role |
|---|---|
| NOVARTIS PHARMA SAS | sponsor |
| Name |
|---|
| NOVARTIS PHARMA SAS |
| Agency name |
|---|
| CNIL |
['Through organizations (health services or institutions, schools, businesses, etc.)','Medical-administrative database (patients, health insurance/mutual insurance)','Disease and death registry','Through independent healthcare practitioners']
['{"concept":{"vocabURI":"Other","vocab":"CESSDA"},"value":"Other"}']
Access on specific project only
Observational Study
| Start | End |
|---|---|
| 2004-01-01 | 2004-12-31 |
One-time cross-sectional study
| Standard |
|---|
| ['GINA classification'] |
{"value":"Restricted access","extLink":[{"title":"COAR","uri":"http://purl.org/coar/access_right/c_16ec"}]}
| Name | |
|---|---|
| Anne;PONTHIEUX | anne.ponthieux@novartis.com |